These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 15922048

  • 1. Age-related impairments in operant DMTP performance in the PS2APP mouse, a transgenic mouse model of Alzheimer's disease.
    Woolley ML, Ballard TM.
    Behav Brain Res; 2005 Jun 20; 161(2):220-8. PubMed ID: 15922048
    [Abstract] [Full Text] [Related]

  • 2. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
    Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L, Kaufmann WE, Vehmas A, Andreasson KI.
    Neuroscience; 2006 Sep 01; 141(3):1149-62. PubMed ID: 16753269
    [Abstract] [Full Text] [Related]

  • 3. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O.
    Ann Neurol; 2004 Jun 01; 55(6):801-14. PubMed ID: 15174014
    [Abstract] [Full Text] [Related]

  • 4. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, Vassar R, Disterhoft JF.
    Eur J Neurosci; 2006 Jan 01; 23(1):251-60. PubMed ID: 16420434
    [Abstract] [Full Text] [Related]

  • 5. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR.
    Neurobiol Dis; 2005 Apr 01; 18(3):602-17. PubMed ID: 15755686
    [Abstract] [Full Text] [Related]

  • 6. Characterization of cognition alteration across the course of the disease in APP751SL mice with parallel estimation of cerebral Abeta deposition.
    Blanchard J, Decorte L, Noguès X, Micheau J.
    Behav Brain Res; 2009 Jul 19; 201(1):147-57. PubMed ID: 19428628
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J.
    Neuroscience; 2006 Nov 03; 142(4):941-52. PubMed ID: 16938404
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease.
    Kobayashi DT, Chen KS.
    Genes Brain Behav; 2005 Apr 03; 4(3):173-96. PubMed ID: 15810905
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Progressive cognitive decline in a transgenic mouse model of Alzheimer's disease overexpressing mutant hAPPswe.
    Middei S, Daniele S, Caprioli A, Ghirardi O, Ammassari-Teule M.
    Genes Brain Behav; 2006 Apr 03; 5(3):249-56. PubMed ID: 16594978
    [Abstract] [Full Text] [Related]

  • 14. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A, Döbeli H, Bohrmann B.
    Neuroscience; 2006 Dec 01; 143(2):461-75. PubMed ID: 17008022
    [Abstract] [Full Text] [Related]

  • 15. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels.
    Pardon MC, Sarmad S, Rattray I, Bates TE, Scullion GA, Marsden CA, Barrett DA, Lowe J, Kendall DA.
    Neurobiol Aging; 2009 Jul 01; 30(7):1099-113. PubMed ID: 18023506
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms.
    Costa DA, Cracchiolo JR, Bachstetter AD, Hughes TF, Bales KR, Paul SM, Mervis RF, Arendash GW, Potter H.
    Neurobiol Aging; 2007 Jun 01; 28(6):831-44. PubMed ID: 16730391
    [Abstract] [Full Text] [Related]

  • 18. Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease.
    Pietropaolo S, Feldon J, Yee BK.
    Behav Neurosci; 2008 Aug 01; 122(4):733-47. PubMed ID: 18729626
    [Abstract] [Full Text] [Related]

  • 19. Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice.
    Ozmen L, Albientz A, Czech C, Jacobsen H.
    Neurodegener Dis; 2009 Aug 01; 6(1-2):29-36. PubMed ID: 19066434
    [Abstract] [Full Text] [Related]

  • 20. Early discrimination reversal learning impairment and preserved spatial learning in a longitudinal study of Tg2576 APPsw mice.
    Zhuo JM, Prescott SL, Murray ME, Zhang HY, Baxter MG, Nicolle MM.
    Neurobiol Aging; 2007 Aug 01; 28(8):1248-57. PubMed ID: 16828204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.